(Q36942143)
Statements
1 reference
Assessing the benefit-risk for new drugs: are the FDA's Endocrinologic and Metabolic Drugs Advisory Committee and the Division of Metabolism and Endocrinology Products in sync? (English)
1 reference
Eric P Brass
1 reference
21 May 2013
1 reference
1 reference
1823-1826
1 reference
Identifiers
1 reference
1 reference
1 reference